The Department of Defense officially terminated its contract with biotech company Sarepta(NASDAQ:SRPT)
In the following video, health-care analysts Max Macaluso and David Williamson discuss this news and what investors should be watching at Sarepta going forward.
Max Macaluso, David Williamson, and The Motley Fool have no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.